2023-05-22 08:06
(389 d 08:53 ago)

Posting: # 23563
Views: 1,258

 regulatory guideline [Regulatives / Guidelines]

In bioequivalence study if any adverse event is ongoing; we can collect safety sample or end study sample before completion of adverse event. if any reference guideline pls show
UA Flag
 Admin contact
23,056 posts in 4,840 threads, 1,641 registered users;
141 visitors (0 registered, 141 guests [including 62 identified bots]).
Forum time: 17:00 CEST (Europe/Vienna)

Exploratory analysis: The art of finding a Rembrandt
in a Jackson Pollock.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz